Singapore Banking Sector - Phillip Securities Pte Ltd
Singapore Banking Sector - Phillip Securities Pte Ltd
Singapore Banking Sector - Phillip Securities Pte Ltd
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />
Results Season Takeaways<br />
Report type: Update<br />
<strong>Sector</strong> Overview<br />
The <strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong> provides traditional lending<br />
and depository functions, as well as other services in the<br />
areas of commercial banking, financial advisory, asst<br />
management, insurance broking and capital market<br />
services.<br />
Post Results Highlight<br />
Non Interest income<br />
Non Interest Income beat expectations due to strong<br />
performance of net trading income<br />
Net trading income likely due to strong performances in<br />
indices in 1Q12 leading higher valuation gains<br />
Strong performances unlikely to be repeated in 2Q12 or<br />
FY12, given currently macroeconomic uncertainties.<br />
Net Interest Margins<br />
NIMs improved 1-4bps in 1Q12, with OCBC’s NIMs<br />
growth weakest at 1bps and DBS strongest at 4bps<br />
DBS and OCBC guides possible upside potentials while<br />
UOB guides that NIMs may have peaked<br />
We expect NIMs to remain around current range<br />
Loans growth outlook<br />
Loans growth have slowed as guided by Managements<br />
General Commerce loans slow due to decrease in RMB<br />
appreciation driven trades, but expected to remain<br />
relatively strong for the rest of FY2012<br />
Strong growth of USD deposits to benefit growth of trade<br />
finance business for UOB and DBS<br />
We expect loans to SMEs to drive loans growth for<br />
FY2012, and contributing to growth of non-interest<br />
income<br />
Investment actions<br />
Based on 5 year historical price to book, all three banks are<br />
below historical mean PB ratio, possibly indicating cheap<br />
pricing based on valuations. While uncertainties in the<br />
current macroeconomic conditions continue to suppress<br />
prices, we think that DBS will outperform its local peers with<br />
continued growth and strong performance. We rate DBS as<br />
“Accumulate” while maintaining our “Neutral” call on UOB<br />
and OCBC.<br />
MICA (P) 012/01/2012<br />
Ref. No.: SG2012_0136 1 of 10<br />
<strong>Phillip</strong> <strong>Securities</strong> Research <strong>Pte</strong> <strong>Ltd</strong><br />
18 May 2012<br />
<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />
Company Rating Price TP Upside M.Cap.<br />
(S$) (S$) (%) (US$'mn)<br />
DBS Group Holdings <strong>Ltd</strong> Accumulate 13.30 14.90 12.0% 25,220<br />
Overseas Chinese<br />
<strong>Banking</strong> Corp Neutral 8.43 8.20 -2.7% 22,639<br />
United Overseas Bank Neutral 17.48 17.50 0.1% 21,582<br />
Source: Bloomberg, PSR<br />
Analyst<br />
Ken Ang<br />
Kenangw y@phillip.com.sg<br />
Tel : (65) 6531 1793
<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />
<strong>Singapore</strong> Equities Research<br />
18 May 2012<br />
Earnings surprise largely attributed to likely nonrecurring<br />
strong performance of net trading income<br />
Fig 1: Strong performance of Indices supported net<br />
trading income in 1Q12, but largely flat since then<br />
FTSE Straits Times Index – trending downwards since<br />
1Q12, expected to be relatively flat for rest of FY2012<br />
FTSE Bursa Malaysia KLCI – Growth may be further<br />
stimulated with possible policy rate cuts<br />
Indonesia Sharia Stock Index – higher highs since 1Q12,<br />
expected to perform relatively stronger than the STI<br />
Thailand SET Index– higher highs since 1Q12, expected to<br />
perform relatively stronger than the STI<br />
Source: bigcharts.marketwatch.com, <strong>Phillip</strong> <strong>Securities</strong> Research<br />
2 of 10<br />
Higher trading income contributed largely to the positive<br />
earnings surprise. Trading income generally refers to<br />
income from customer flow of treasury products, and from<br />
trading activities including realized gains from sale of AFS<br />
securities, and unrealized valuation gains on other products<br />
such as FVTPL. The strong performances of the indices in<br />
the Asean region may have supported the stronger net<br />
trading income through higher equity valuation gains, and<br />
greater opportunities to realize gains on AFS.<br />
Moving forward, our strategist believes that while the market<br />
outlook for export dependant countries such as <strong>Singapore</strong><br />
and Taiwan would be rather flat, countries such as Malaysia,<br />
Indonesia and Thailand are expected to experience<br />
relatively better economic growth. For Malaysia, given the<br />
lower and more stable inflation rate, growth may be further<br />
stimulated with policy rate cuts. This may benefit bonds due<br />
to their inverse correlations with interest rates, while equity<br />
securities perform in tandem with the Malaysian market.<br />
However, as observed from the graphs in Fig 1, it is unlikely<br />
for 1Q12’s strong net trading income to be repeated in 2Q12<br />
and likely for the rest of FY2012, other than realizing current<br />
valuation gains on AFS. Downward potentials to net trading<br />
income may arise from further slowdown in the global<br />
economy or from adverse developments on the debt crisis in<br />
Europe. We are unable to do a comparison between the<br />
three banks due to lack of disclosure by the banks.<br />
NIMs improved in 1Q12 from better loans pricing – likely<br />
to be stable and remain within current range for FY2012<br />
Fig 2: NIMS have been trending downwards but<br />
seems to have bottomed in 3Q11<br />
2.25<br />
2.15<br />
2.05<br />
1.95<br />
1.85<br />
1.75<br />
1.65<br />
OCBC DBS<br />
UOB<br />
2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 1Q12<br />
Source: Company data, <strong>Phillip</strong> <strong>Securities</strong> Research<br />
NIMs have expanded across the three banks in 1Q12, with<br />
DBS the strongest at 4bps, and OCBC weakest at 1bp.<br />
UOB continued its strong rebound, increasing 3bps to<br />
register a commendable 9bps increase since hitting lows in<br />
3Q11. As previously highlighted in our 4Q11 results season<br />
takeaway report, UOB’s increase in NIMS is likely due to the<br />
offering of higher maturity loans, therefore commanding a<br />
liquidity premium. However, longer maturity loans also pose<br />
higher interest rate risks (for fixed rate loans) and credit risks.<br />
DBS and OCBC has commented that there may be potential<br />
for further NIMs expansion, while UOB guided that NIMs<br />
may have peaked. With UOB’s main overseas markets<br />
being in countries with relatively better market outlooks such<br />
as Malaysia, Indonesia and Thailand, we prefer UOB for its<br />
current high NIMs ability to increase NIMs significantly.
<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />
<strong>Singapore</strong> Equities Research<br />
18 May 2012<br />
Loans growth expected to gather momentum from<br />
slower 1Q12<br />
Fig 3: Q-Q Loans growth momentum slows in 1Q12<br />
12%<br />
10%<br />
8%<br />
6%<br />
4%<br />
2%<br />
0%<br />
-2%<br />
OCBC DBS<br />
UOB Total<br />
2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 1Q12<br />
Fig 4: Q-Q Total loans growth among local banks<br />
negative in a few industries, but remain relatively<br />
strong in housing, FIs, Professional & private loans<br />
Total loans q-q grow th 2Q11 3Q11 4Q11 1Q12<br />
Agriculture<br />
-4.0% 9.1% 18.2% 1.3%<br />
Manufacturing<br />
12.0% 5.0% 7.2% 2.4%<br />
Building and construction 3.8% 8.4% 8.0% 1.8%<br />
General commerce<br />
24.0% 20.9% 1.9% -1.2%<br />
Transport<br />
6.1% 4.7% 4.4% -2.5%<br />
Financial institutions<br />
3.2% 9.3% 1.0% 4.9%<br />
Professional and private (business) 7.0% 3.0% 7.5% 2.1%<br />
Others<br />
10.6% 5.3% 0.3% -4.8%<br />
Housing<br />
3.0% 4.8% 3.6% 3.1%<br />
Total loans<br />
7.6% 8.0% 4.2% 1.3%<br />
Source: Company data, <strong>Phillip</strong> <strong>Securities</strong> Research<br />
Loans growth momentum has slowed, but remains positive<br />
for all three banks on an average loan balance basis. With<br />
similar guidance of low teens loans growth, we expect<br />
growth to increase for the next few quarters. We note that<br />
current gross balances were likely reduced due to the<br />
appreciation of the <strong>Singapore</strong> Dollar in 1Q12 against the<br />
Asian currencies.<br />
Fig 5: General Commerce loans VS Total Loans<br />
Growth – growth may continue in FY2012<br />
40%<br />
30%<br />
20%<br />
10%<br />
0%<br />
-10%<br />
-20%<br />
OCBC DBS<br />
UOB Total<br />
2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 1Q12<br />
Source: Company data, <strong>Phillip</strong> <strong>Securities</strong> Research<br />
General Commerce (GC) loans have slowed, registering its<br />
first negative q-q growth since 3Q09, based on the total GC<br />
loans across the three banks. OCBC’s CEO Samuel Tsien<br />
has guided that the drop was due to a decrease in demand<br />
from the RMB appreciation driven trade financing by<br />
customers from China, as written in our OCBC 1Q12 results<br />
report dd 11 May 2012.<br />
3 of 10<br />
We expect GC loans to continue its growth in FY2012 as 1)<br />
New opportunities have risen from the deleveraging of<br />
global banks as highlighted in our <strong>Sector</strong> reports. 2)<br />
Success of <strong>Singapore</strong>’s Global Trader Program in increasing<br />
trading activities with <strong>Singapore</strong> as companies’ regional<br />
base. 3) An increase in intra Asia trade volumes.<br />
Due to the attractive returns, short term commitments and<br />
safe quality of assets as these loans are typically fully<br />
collateralized, we expect General Commerce to continue<br />
healthy loans growth in FY12. The three banks have also<br />
built up a larger funding base of USD deposits and<br />
wholesale funding, giving them the liquidity required to<br />
increase USD denominated lending.<br />
Fig 6: USD LDR continues to decrease as banks<br />
boost USD liquidity through higher deposits (UOB<br />
figs. not available)<br />
50,000<br />
40,000<br />
30,000<br />
20,000<br />
10,000<br />
0<br />
OCBC US$ DBS US$<br />
OCBC LDR DBS LDR<br />
2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 1Q12<br />
Source: Company data, <strong>Phillip</strong> <strong>Securities</strong> Research<br />
180%<br />
170%<br />
160%<br />
150%<br />
140%<br />
130%<br />
120%<br />
110%<br />
100%<br />
DBS continues to enjoy an advantage in General commerce<br />
loans due to a larger and more established presence, while<br />
UOB may perform better than OCBC due to better liquidity<br />
management based on the LDR ratios.<br />
Rise of the SMEs – <strong>Singapore</strong> and Abroad<br />
Based on SPRING <strong>Singapore</strong>, 99% of all enterprises in<br />
<strong>Singapore</strong> are SMEs, contributing over 50% of <strong>Singapore</strong>’s<br />
GDP. Growth is likely further spurred by the low interest rate<br />
environment, and increase in intra Asian trades as the<br />
neighboring Asian countries continue to grow, although at a<br />
slower pace. The local banks have stepped in, increasing<br />
efforts to provide loans and transaction banking services,<br />
including trade financing and cash management services.<br />
While competition remains stiff for MNCs and larger SMEs,<br />
the relatively smaller sized SMEs are relatively underserved<br />
and provide opportunities for banks. Transaction <strong>Banking</strong> is<br />
especially lucrative given the potential fees and<br />
commissions and lower capital requirements.<br />
Key risks for the <strong>Sector</strong><br />
A worsening global economy may result in rise of NPLs and<br />
credit costs, as affected customers, especially SMEs and<br />
unsecured consumer loans, default on loan repayments.<br />
This may result in reduced net profits.<br />
The return of US banks flushed with USD liquidity, as<br />
suggested by OCBC’s CEO, re-entering the Asian markets<br />
may provide competition to the <strong>Singapore</strong> banks and<br />
increase NIMS pressure in the region.<br />
90%
<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />
<strong>Singapore</strong> Equities Research<br />
18 May 2012<br />
Com pany Rating FYE Price TP Upside Market Ent. Market Ent.<br />
Equity Multiple (X) Dividend Yield (%)<br />
Market price as of:<br />
Cap. Value Cap. Value Net Incom e Book Value<br />
18-May-12 (%) (S$'m n) (S$'m n) (US$'mn)(US$'mn) FY10 FY11 FY12E FY10 FY11 FY12E FY10 FY11 FY12E<br />
DBS Group Holdings <strong>Ltd</strong> Accumulate Dec 13.30 14.90 12.0% 32,140 38,494 25,220 30,277 19.7 10.6 9.3 1.2 1.1 1.0 4.2% 4.2% 4.3%<br />
Overseas Chinese <strong>Banking</strong> Corp Neutral Dec 8.43 8.20 -2.7% 28,850 19,710 22,639 15,366 12.8 12.5 11.0 1.5 1.4 1.3 3.6% 3.6% 3.6%<br />
United Overseas Bank<br />
Source: Bloomberg, PSR est.<br />
Neutral Dec 17.48 17.50 0.1% 27,503 26,169 21,582 20,521 10.2 11.8 10.5 1.4 1.3 1.2 4.0% 3.4% 3.4%<br />
4 of 10
<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />
<strong>Singapore</strong> Equities Research<br />
18 May 2012<br />
Oversea-Chinese <strong>Banking</strong> Corp – Insurance “wildcard”<br />
2,500<br />
2,000<br />
1,500<br />
1,000<br />
500<br />
0<br />
2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 1Q12<br />
DBS Group Holdings – Most stable Non II earnings<br />
2,500<br />
2,000<br />
1,500<br />
1,000<br />
500<br />
0<br />
2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 1Q12<br />
United Overseas Bank <strong>Ltd</strong><br />
2,500<br />
2,000<br />
1,500<br />
1,000<br />
500<br />
2.8<br />
2.6<br />
2.4<br />
2.2<br />
2.0<br />
1.8<br />
1.6<br />
1.4<br />
1.2<br />
1.0<br />
0.8<br />
2.0<br />
1.8<br />
1.6<br />
1.4<br />
1.2<br />
1.0<br />
0.8<br />
0.6<br />
0.4<br />
0<br />
2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 1Q12<br />
OCBC - PB ratio<br />
SD+1<br />
SD-1<br />
May-07 Jan-08 Sep-08 May-09 Jan-10 Sep-10 May-11 Jan-12<br />
DBS - PB ratio<br />
SD+1<br />
SD-1<br />
May-07 Jan-08 Sep-08 May-09 Jan-10 Sep-10 May-11 Jan-12<br />
Source: Company data, Bloomberg, <strong>Phillip</strong> <strong>Securities</strong> Research<br />
1.83<br />
1.51<br />
1.23 1.20<br />
1.49<br />
1.23<br />
1.08<br />
0.98<br />
5 of 10<br />
- Net profit y-y growth slower than Total revenue growth<br />
8,000<br />
7,000<br />
6,000<br />
5,000<br />
4,000<br />
3,000<br />
2,000<br />
1,000<br />
0<br />
FY2009 FY2010 FY2011 FY2012<br />
Non Int Inc<br />
Fees and<br />
Comm<br />
NII<br />
Net Profit<br />
PPOP<br />
- Increasing y-y earnings from Non II, High net profit growth<br />
8,000<br />
7,000<br />
6,000<br />
5,000<br />
4,000<br />
3,000<br />
2,000<br />
1,000<br />
0<br />
FY2009 FY2010 FY2011 FY2012<br />
- Minimal y-y growth in total revenue<br />
8,000<br />
7,000<br />
6,000<br />
5,000<br />
4,000<br />
3,000<br />
2,000<br />
1,000<br />
2.4<br />
2.2<br />
2.0<br />
1.8<br />
1.6<br />
1.4<br />
1.2<br />
1.0<br />
0.8<br />
19.0<br />
17.0<br />
15.0<br />
13.0<br />
11.0<br />
9.0<br />
7.0<br />
0<br />
FY2009 FY2010 FY2011 FY2012<br />
UOB - PB ratio<br />
SD+1<br />
SD-1<br />
OCBC - PE ratio<br />
SD+1<br />
SD-1<br />
Non Int Inc<br />
Fees and<br />
Comm<br />
NII<br />
Net Profit<br />
PPOP<br />
Non Int Inc<br />
Fees and<br />
Comm<br />
NII<br />
Net Profit<br />
PPOP<br />
May-07 Jan-08 Sep-08 May-09 Jan-10 Sep-10 May-11 Jan-12<br />
May-07 Jan-08 Sep-08 May-09 Jan-10 Sep-10 May-11 Jan-12<br />
Source: Company data, Bloomberg, <strong>Phillip</strong> <strong>Securities</strong> Research<br />
1.83<br />
1.57<br />
1.27 1.31<br />
15.33<br />
13.64<br />
11.94
<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />
<strong>Singapore</strong> Equities Research<br />
18 May 2012<br />
25.0<br />
20.0<br />
15.0<br />
10.0<br />
5.0<br />
DBS - PE ratio<br />
SD+1<br />
SD-1<br />
-<br />
May-07 Jan-08 Sep-08 May-09 Jan-10 Sep-10 May-11 Jan-12<br />
6<br />
4<br />
2<br />
0<br />
-4<br />
-6<br />
-8<br />
25 April 12 rebased<br />
-2<br />
4/25/2012 5/1/2012 5/7/2012 5/13/2012<br />
8<br />
6<br />
4<br />
2<br />
0<br />
-4<br />
-6<br />
-8<br />
OCB C<br />
DBS<br />
UOB<br />
STI<br />
1 month rebased<br />
4/17/2012 -2<br />
4/25/2012 5/3/2012 5/11/2012<br />
12<br />
10<br />
8<br />
6<br />
4<br />
2<br />
0<br />
-2<br />
-4<br />
-6<br />
-8<br />
-10<br />
OCBC<br />
DBS<br />
UOB<br />
STI<br />
OCBC<br />
DB S<br />
UOB<br />
STI<br />
3 months rebased<br />
2/17/2012 3/8/2012 3/28/2012 4/17/2012 5/7/2012<br />
Source: Company data, Bloomberg, <strong>Phillip</strong> <strong>Securities</strong> Research<br />
15.37<br />
12.47<br />
9.56<br />
6 of 10<br />
20.0<br />
18.0<br />
16.0<br />
14.0<br />
12.0<br />
10.0<br />
8.0<br />
6.0<br />
25<br />
20<br />
15<br />
10<br />
5<br />
0<br />
-10<br />
-15<br />
10<br />
5<br />
0<br />
-10<br />
-15<br />
-20<br />
-25<br />
-30<br />
25<br />
20<br />
15<br />
10<br />
5<br />
0<br />
-5<br />
-10<br />
-15<br />
-20<br />
-25<br />
-30<br />
UOB - PE ratio<br />
SD+1<br />
SD-1<br />
May-07 Jan-08 Sep-08 May-09 Jan-10 Sep-10 May-11 Jan-12<br />
OCBC<br />
DBS<br />
UOB<br />
STI<br />
2 Year rebased<br />
5/19/2010 10/19/2010 3/19/2011 8/19/2011 1/19/2012<br />
OCB C<br />
DBS<br />
UOB<br />
STI<br />
1 Year rebased<br />
5/19/2011 -5 7/19/2011 9/19/201111/19/20111/19/2012 3/19/2012<br />
OCB C<br />
DBS<br />
UOB<br />
STI<br />
6 months rebased<br />
15.17<br />
13.02<br />
10.87<br />
11/18/201 -5 12/18/20111/18/2012 2/18/20123/18/2012 4/18/2012 5/18/2012<br />
Source: Company data, Bloomberg, <strong>Phillip</strong> <strong>Securities</strong> Research
<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />
<strong>Singapore</strong> Equities Research<br />
18 May 2012<br />
Important Information<br />
This publication is prepared by <strong>Phillip</strong> <strong>Securities</strong> Research <strong>Pte</strong> <strong>Ltd</strong>., 250 North Bridge Road, #06-00, Raffles City<br />
Tower, <strong>Singapore</strong> 179101 (Registration Number: 198803136N), which is regulated by the Monetary Authority of<br />
<strong>Singapore</strong> (“<strong>Phillip</strong> <strong>Securities</strong> Research”). By receiving or reading this publication, you agree to be bound by the terms<br />
and limitations set out below.<br />
This publication has been provided to you for personal use only and shall not be reproduced, distributed or published<br />
by you in whole or in part, for any purpose. If you have received this document by mistake, please delete or destroy it,<br />
and notify the sender immediately. <strong>Phillip</strong> <strong>Securities</strong> Research shall not be liable for any direct or consequential loss<br />
arising from any use of material contained in this publication.<br />
The information contained in this publication has been obtained from public sources, which <strong>Phillip</strong> <strong>Securities</strong> Research<br />
has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions<br />
(collectively, the “Research”) contained in this publication are based on such information and are expressions of belief<br />
of the individual author or the indicated source (as applicable) only. <strong>Phillip</strong> <strong>Securities</strong> Research has not verified this<br />
information and no representation or warranty, express or implied, is made that such information or Research is<br />
accurate, complete, appropriate or verified or should be relied upon as such. Any such information or Research<br />
contained in this publication is subject to change, and <strong>Phillip</strong> <strong>Securities</strong> Research shall not have any responsibility to<br />
maintain or update the information or Research made available or to supply any corrections, updates or releases in<br />
connection therewith. In no event will <strong>Phillip</strong> <strong>Securities</strong> Research or persons associated with or connected to <strong>Phillip</strong><br />
<strong>Securities</strong> Research, including but not limited its officers, directors, employees or persons involved in the preparation<br />
or issuance of this report, (i) be liable in any manner whatsoever for any consequences (including but not limited to<br />
any special, direct, indirect, incidental or consequential losses, loss of profits and damages) of any reliance or usage<br />
of this publication or (ii) accept any legal responsibility from any person who receives this publication, even if it has<br />
been advised of the possibility of such damages. You must make the final investment decision and accept all<br />
responsibility for your investment decision, including, but not limited to your reliance on the information, data and/or<br />
other materials presented in this publication.<br />
Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this material are as of the date<br />
indicated and are subject to change at any time without prior notice.<br />
Past performance of any product referred to in this publication is not indicative of future results.<br />
This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This<br />
publication should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own<br />
independent verification and exercise of judgment. The fact that this publication has been made available constitutes<br />
neither a recommendation to enter into a particular transaction, nor a representation that any product described in this<br />
material is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may<br />
be described in this publication involve significant risks and may not be suitable for all investors, and that any decision<br />
to enter into transactions involving such products should not be made, unless all such risks are understood and an<br />
independent determination has been made that such transactions would be appropriate. Any discussion of the risks<br />
contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete<br />
discussion of such risks.<br />
Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any<br />
decision to purchase any product mentioned in this research should take into account existing public information,<br />
including any registered prospectus in respect of such product.<br />
<strong>Phillip</strong> <strong>Securities</strong> Research, or persons associated with or connected to <strong>Phillip</strong> <strong>Securities</strong> Research, including but not<br />
limited to its officers, directors, employees or persons involved in the preparation or issuance of this report, may<br />
provide an array of financial services to a large number of corporations in <strong>Singapore</strong> and worldwide, including but not<br />
limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting<br />
activities), brokerage or securities trading activities. <strong>Phillip</strong> <strong>Securities</strong> Research, or persons associated with or<br />
connected to <strong>Phillip</strong> <strong>Securities</strong> Research, including but not limited to its officers, directors, employees or persons<br />
involved in the preparation or issuance of this report, may have participated in or invested in transactions with the<br />
issuer(s) of the securities mentioned in this publication, and may have performed services for or solicited business<br />
from such issuers. Additionally, <strong>Phillip</strong> <strong>Securities</strong> Research, or persons associated with or connected to <strong>Phillip</strong><br />
<strong>Securities</strong> Research, including but not limited to its officers, directors, employees or persons involved in the<br />
7 of 10
<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />
<strong>Singapore</strong> Equities Research<br />
18 May 2012<br />
preparation or issuance of this report, may have provided advice or investment services to such companies and<br />
investments or related investments, as may be mentioned in this publication.<br />
<strong>Phillip</strong> <strong>Securities</strong> Research or persons associated with or connected to <strong>Phillip</strong> <strong>Securities</strong> Research, including but not<br />
limited to its officers, directors, employees or persons involved in the preparation or issuance of this report may, from<br />
time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase<br />
or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other<br />
compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars<br />
and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign<br />
currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price<br />
or income return of the investment.<br />
To the extent permitted by law, <strong>Phillip</strong> <strong>Securities</strong> Research, or persons associated with or connected to <strong>Phillip</strong><br />
<strong>Securities</strong> Research, including but not limited to its officers, directors, employees or persons involved in the<br />
preparation or issuance of this report, may at any time engage in any of the above activities as set out above or<br />
otherwise hold a interest, whether material or not, in respect of companies and investments or related investments,<br />
which may be mentioned in this publication. Accordingly, information may be available to <strong>Phillip</strong> <strong>Securities</strong> Research,<br />
or persons associated with or connected to <strong>Phillip</strong> <strong>Securities</strong> Research, including but not limited to its officers,<br />
directors, employees or persons involved in the preparation or issuance of this report, which is not reflected in this<br />
material, and <strong>Phillip</strong> <strong>Securities</strong> Research, or persons associated with or connected to <strong>Phillip</strong> <strong>Securities</strong> Research,<br />
including but not limited to its officers, directors, employees or persons involved in the preparation or issuance of this<br />
report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following<br />
its publication. <strong>Phillip</strong> <strong>Securities</strong> Research, or persons associated with or connected to <strong>Phillip</strong> <strong>Securities</strong> Research,<br />
including but not limited its officers, directors, employees or persons involved in the preparation or issuance of this<br />
report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of<br />
this material.<br />
The information, tools and material presented herein are not directed, intended for distribution to or use by, any person<br />
or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the<br />
applicable law or regulation or which would subject <strong>Phillip</strong> <strong>Securities</strong> Research to any registration or licensing or other<br />
requirement, or penalty for contravention of such requirements within such jurisdiction.<br />
Section 27 of the Financial Advisers Act (Cap. 110) of <strong>Singapore</strong> and the MAS Notice on Recommendations on<br />
Investment Products (FAA-N01) do not apply in respect of this publication.<br />
This material is intended for general circulation only and does not take into account the specific investment objectives,<br />
financial situation or particular needs of any particular person. The products mentioned in this material may not be<br />
suitable for all investors and a person receiving or reading this material should seek advice from a professional and<br />
financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such<br />
products, taking into account the specific investment objectives, financial situation or particular needs of that person,<br />
before making a commitment to invest in any of such products.<br />
Please contact <strong>Phillip</strong> <strong>Securities</strong> Research at [65 65311240] in respect of any matters arising from, or in connection<br />
with, this document.<br />
This report is only for the purpose of distribution in <strong>Singapore</strong>.<br />
8 of 10
<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />
<strong>Singapore</strong> Equities Research<br />
18 May 2012<br />
Contact Information (<strong>Singapore</strong> Research Team)<br />
Chan Wai Chee Lee Kok Joo, CFA Joshua Tan<br />
CEO, Research Head of Research Strategist<br />
Special Opportunities S-Chips, Strategy +65 6531 1249<br />
+65 6531 1231 +65 6531 1685 joshuatan@phillip.com.sg<br />
yebo@phillip.com.sg leekj@phillip.com.sg<br />
Magdalene Choong Go Choon Koay, Bryan Derrick Heng<br />
Investment Analyst Investment Analyst Investment Analyst<br />
SG & US Financials, Gaming Property Transportation, Telecom.<br />
+65 6531 1791 +65 6531 1792 +65 6531 1221<br />
magdalenechoongss@phillip.com.sg gock@phillip.com.sg derrickhengch@phillip.com.sg<br />
Travis Seah Ken Ang Peter Lee<br />
Investment Analyst Investment Analyst Research Assistant<br />
REITS Financials General Enquiries<br />
+65 6531 1229 +65 6531 1793 +65 6531 1240 (Phone)<br />
travisseahhk@phillip.com.sg kenangwy@phillip.com.sg +65 6336 7607 (Fax)<br />
research@phillip.com.sg<br />
9 of 10
<strong>Singapore</strong> <strong>Banking</strong> <strong>Sector</strong><br />
<strong>Singapore</strong> Equities Research<br />
18 May 2012<br />
Contact Information (Regional Member Companies)<br />
SINGAPORE<br />
<strong>Phillip</strong> <strong>Securities</strong> <strong>Pte</strong> <strong>Ltd</strong><br />
Raffles City Tower<br />
250, North Bridge Road #06-00<br />
<strong>Singapore</strong> 179101<br />
Tel : (65) 6533 6001<br />
Fax : (65) 6535 6631<br />
Website: www.poems.com.sg<br />
HONG KONG<br />
<strong>Phillip</strong> <strong>Securities</strong> (HK) <strong>Ltd</strong><br />
Exchange Participant of the Stock Exchange of Hong Kong<br />
11/F United Centre 95 Queensway<br />
Hong Kong<br />
Tel (852) 22776600<br />
Fax (852) 28685307<br />
Websites: www.phillip.com.hk<br />
INDONESIA<br />
PT <strong>Phillip</strong> <strong>Securities</strong> Indonesia<br />
ANZ Tower Level 23B,<br />
Jl Jend Sudirman Kav 33A<br />
Jakarta 10220 – Indonesia<br />
Tel (62-21) 57900800<br />
Fax (62-21) 57900809<br />
Website: www.phillip.co.id<br />
THAILAND<br />
<strong>Phillip</strong> <strong>Securities</strong> (Thailand) Public Co. <strong>Ltd</strong><br />
15th Floor, Vorawat Building,<br />
849 Silom Road, Silom, Bangrak,<br />
Bangkok 10500 Thailand<br />
Tel (66-2) 6351700 / 22680999<br />
Fax (66-2) 22680921<br />
Website www.phillip.co.th<br />
UNITED KINGDOM<br />
King & Shaxson Capital Limited<br />
6th Floor, Candlewick House,<br />
120 Cannon Street,<br />
London, EC4N 6AS<br />
Tel (44-20) 7426 5950<br />
Fax (44-20) 7626 1757<br />
Website: www.kingandshaxson.com<br />
AUSTRALIA<br />
<strong>Phillip</strong>Capital Australia<br />
Level 37, 530 Collins Street,<br />
Melbourne, Victoria 3000, Australia<br />
Tel (613) 96298380<br />
Fax (613) 96148309<br />
Website: www.phillipcapital.com.au<br />
10 of 10<br />
MALAYSIA<br />
<strong>Phillip</strong> Capital Management Sdn Bhd<br />
B-3-6 Block B Level 3 Megan Avenue II,<br />
No. 12, Jalan Yap Kwan Seng, 50450<br />
Kuala Lumpur<br />
Tel (603) 21628841<br />
Fax (603) 21665099<br />
Website: www.poems.com.my<br />
JAPAN<br />
<strong>Phillip</strong> <strong>Securities</strong> Japan, <strong>Ltd</strong>.<br />
4-2 Nihonbashi Kabuto-cho<br />
Chuo-ku, Tokyo 103-0026<br />
Tel (81-3) 36662101<br />
Fax (81-3) 36666090<br />
Website:www.phillip.co.jp<br />
CHINA<br />
<strong>Phillip</strong> Financial Advisory (Shanghai) Co. <strong>Ltd</strong><br />
No 550 Yan An East Road,<br />
Ocean Tower Unit 2318,<br />
Postal code 200001<br />
Tel (86-21) 51699200<br />
Fax (86-21) 63512940<br />
Website: www.phillip.com.cn<br />
FRANCE<br />
King & Shaxson Capital Limited<br />
3rd Floor, 35 Rue de la Bienfaisance 75008<br />
Paris France<br />
Tel (33-1) 45633100<br />
Fax (33-1) 45636017<br />
Website: www.kingandshaxson.com<br />
UNITED STATES<br />
<strong>Phillip</strong> Futures Inc<br />
141 W Jackson Blvd Ste 3050<br />
The Chicago Board of Trade Building<br />
Chicago, IL 60604 USA<br />
Tel +1.312.356.9000<br />
Fax +1.312.356.9005